Update date
31 Jan 2026
Shareable Research Card
PMCB - PharmaCyte Biotech, Inc. Earnings Per Share, Basic
This metric view shows PMCB - PharmaCyte Biotech, Inc. earnings per share, basic history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- -0.17
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Jan 2026
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2025.
- Latest reported value on this page: -0.17.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Earnings Per Share, Basic
Latest reported earnings per share, basic: -0.17. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2025
Ownership context was refreshed from SEC Forms 3/4/5 filed on 18 Mar 2026.
Benchmark Context
How Earnings Per Share, Basic compares with peers
PharmaCyte Biotech, Inc. is outside the visible top 120 companies for earnings per share, basic in the current sample.
Compared with
Compared with 120 companies reporting earnings per share, basic in USD/shares. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Earnings Per Share, Basic is up about 61% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2026.
- Nearby companies in this sample: MachTen, Inc. and Blue World Acquisition Corp.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
PharmaCyte Biotech, Inc.: Earnings Per Share, Basic
Latest period: Q4 2025. Period end: 31 Jan 2026. Units: USD/shares. Frequency: quarterly and annual.
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Metric Snapshot
- Latest value
- -0.17
- Coverage range
- 31 Jul 2010 - 31 Jan 2026
- Fact rows
- 47
What This Metric Tells You
- Shows the reported level of earnings per share, basic over 31 Jul 2010 - 31 Jan 2026.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 47 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
- Use the TTM line to smooth quarter-to-quarter noise.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Earnings Per Share, Basic levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | MachTen, Inc. (mact) | 10,600,000 | Quarter - 30 Jun 2023 | Open MachTen, Inc. Earnings Per Share, Basic |
| 2 | Blue World Acquisition Corp | 5,826,667 | Quarter - 31 Mar 2022 | Open Blue World Acquisition Corp Earnings Per Share, Basic |
| 3 | CCS IX Portfolio Holdings, LLC | 1,879,100 | Year - 31 Dec 2025 | Open CCS IX Portfolio Holdings, LLC Earnings Per Share, Basic |
| 4 | Heidmar Maritime Holdings Corp. (hmr) | 19,932 | Year - 31 Dec 2024 | Open Heidmar Maritime Holdings Corp. Earnings Per Share, Basic |
| 5 | BERKSHIRE HATHAWAY INC (brkb) | 3,035 | Quarter - 31 Dec 2013 | Open BERKSHIRE HATHAWAY INC Earnings Per Share, Basic |
| 6 | HIGHWATER ETHANOL LLC | 1,181 | Quarter - 31 Jan 2026 | Open HIGHWATER ETHANOL LLC Earnings Per Share, Basic |
Metric Details
- Metric
- Earnings Per Share, Basic (EarningsPerShareBasic)
- Taxonomy
- us-gaap
- Units tracked
- USD/shares
- Frequency coverage
- quarterly and annual
- History range
- 31 Jul 2010 - 31 Jan 2026
- Facts on this page
- 47
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
PharmaCyte Biotech, Inc. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.52 | -0.17 | +0.27 | +61% | 01 Nov 2025 | 31 Jan 2026 | 10-Q | 17 Mar 2026 | 2026 | Q3 |
| Q3 2025 | -0.79 | -1.24 | -0.85 | -218% | 01 Aug 2025 | 31 Oct 2025 | 10-Q | 18 Dec 2025 | 2026 | Q2 |
| Q2 2025 | 0.06 | -1.23 | -3.13 | -165% | 01 May 2025 | 31 Jul 2025 | 10-Q | 15 Sep 2025 | 2026 | Q1 |
| Q1 2025 | 3.19 | 2.12 | +2.47 | 01 Feb 2025 | 30 Apr 2025 | 10-K | 11 Aug 2025 | 2025 | FY | |
| Q4 2024 | 0.72 | -0.44 | +0.21 | +32% | 01 Nov 2024 | 31 Jan 2025 | 10-Q | 17 Mar 2026 | 2026 | Q3 |
| Q3 2024 | 0.51 | -0.39 | -0.13 | -50% | 01 Aug 2024 | 31 Oct 2024 | 10-Q | 18 Dec 2025 | 2026 | Q2 |
| Q2 2024 | 0.64 | 1.9 | +2.44 | 01 May 2024 | 31 Jul 2024 | 10-Q | 15 Sep 2025 | 2026 | Q1 | |
| Q1 2024 | -1.8 | -0.35 | -0.33 | -1650% | 01 Feb 2024 | 30 Apr 2024 | 10-K | 11 Aug 2025 | 2025 | FY |
| Q4 2023 | -1.47 | -0.65 | -0.61 | -1525% | 01 Nov 2023 | 31 Jan 2024 | 10-Q | 17 Mar 2025 | 2025 | Q3 |
| Q3 2023 | -0.86 | -0.26 | -0.17 | -189% | 01 Aug 2023 | 31 Oct 2023 | 10-Q | 13 Dec 2024 | 2025 | Q2 |
| Q2 2023 | -0.69 | -0.54 | -0.47 | -671% | 01 May 2023 | 31 Jul 2023 | 10-Q | 17 Sep 2024 | 2025 | Q1 |
| Q1 2023 | -0.22 | -0.02 | -0.49 | -104% | 01 Feb 2023 | 30 Apr 2023 | 10-K | 13 Aug 2024 | 2024 | FY |
| Q4 2022 | 0.27 | -0.04 | 0 | 0% | 01 Nov 2022 | 31 Jan 2023 | 10-Q | 18 Mar 2024 | 2024 | Q3 |
| Q3 2022 | 0.27 | -0.09 | -0.03 | -50% | 01 Aug 2022 | 31 Oct 2022 | 10-Q | 15 Dec 2023 | 2024 | Q2 |
| Q2 2022 | 0.3 | -0.07 | +0.57 | +89% | 01 May 2022 | 31 Jul 2022 | 10-Q | 18 Sep 2023 | 2024 | Q1 |
| Q1 2022 | -0.27 | 0.47 | 01 Feb 2022 | 30 Apr 2022 | 10-K | 31 Jul 2023 | 2023 | FY | ||
| Q4 2021 | -0.04 | 01 Nov 2021 | 31 Jan 2022 | 10-Q | 16 Mar 2023 | 2023 | Q3 | |||
| Q3 2021 | -0.06 | 01 Aug 2021 | 31 Oct 2021 | 10-Q | 14 Dec 2022 | 2022 | Q2 | |||
| Q2 2021 | -0.64 | 01 May 2021 | 31 Jul 2021 | 10-Q | 14 Sep 2022 | 2023 | Q1 | |||
| Q4 2014 | -0.04 | 0 | 0 | 01 Nov 2014 | 31 Jan 2015 | 10-Q | 13 Mar 2015 | 2015 | Q3 | |
| Q3 2014 | -0.04 | -0.01 | 0 | 0% | 01 Aug 2014 | 31 Oct 2014 | 10-Q | 15 Dec 2014 | 2015 | Q2 |
| Q2 2014 | -0.04 | 0 | +0.01 | 01 May 2014 | 31 Jul 2014 | 10-Q | 15 Sep 2014 | 2015 | Q1 | |
| Q1 2014 | -0.05 | -0.03 | -0.03 | 01 Feb 2014 | 30 Apr 2014 | 10-K | 04 Aug 2014 | 2014 | FY | |
| Q4 2013 | -0.02 | 0 | 0 | 01 Nov 2013 | 31 Jan 2014 | 10-Q | 13 Mar 2015 | 2015 | Q3 | |
| Q3 2013 | -0.02 | -0.01 | -0.01 | 01 Aug 2013 | 31 Oct 2013 | 10-Q | 15 Dec 2014 | 2015 | Q2 | |
| Q2 2013 | -0.01 | -0.01 | -0.01 | 01 May 2013 | 31 Jul 2013 | 10-Q | 15 Sep 2014 | 2015 | Q1 | |
| Q1 2013 | 0 | 0 | +0.01 | 01 Feb 2013 | 30 Apr 2013 | 10-K | 04 Aug 2014 | 2014 | FY | |
| Q4 2012 | -0.01 | 0 | 0 | 01 Nov 2012 | 31 Jan 2013 | 10-Q | 17 Mar 2014 | 2014 | Q3 | |
| Q3 2012 | -0.01 | 0 | 0 | 01 Aug 2012 | 31 Oct 2012 | 10-Q | 16 Dec 2013 | 2014 | Q2 | |
| Q2 2012 | -0.01 | 0 | 0 | 01 May 2012 | 31 Jul 2012 | 10-Q | 16 Sep 2013 | 2014 | Q1 | |
| Q1 2012 | -0.01 | -0.01 | -0.01 | 01 Feb 2012 | 30 Apr 2012 | 10-K | 29 Jul 2013 | 2013 | FY | |
| Q4 2011 | 0 | 0 | 0 | 01 Nov 2011 | 31 Jan 2012 | 10-Q | 26 Mar 2013 | 2013 | Q3 | |
| Q3 2011 | 0 | 0 | 0 | 01 Aug 2011 | 31 Oct 2011 | 10-Q | 26 Dec 2012 | 2013 | Q2 | |
| Q2 2011 | 0 | 0 | 0 | 01 May 2011 | 31 Jul 2011 | 10-Q | 19 Sep 2012 | 2013 | Q1 | |
| Q1 2011 | 0 | 0 | 01 Feb 2011 | 30 Apr 2011 | 10-K | 14 Aug 2012 | 2012 | FY | ||
| Q4 2010 | 0 | 01 Nov 2010 | 31 Jan 2011 | 10-Q | 21 Mar 2012 | 2012 | Q3 | |||
| Q3 2010 | 0 | 01 Aug 2010 | 31 Oct 2010 | 10-Q | 15 Dec 2011 | 2012 | Q2 | |||
| Q2 2010 | 0 | 01 May 2010 | 31 Jul 2010 | 10-Q/A | 20 Sep 2011 | 2012 | Q1 |
PharmaCyte Biotech, Inc. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | 3.19 | +4.99 | 01 May 2024 | 30 Apr 2025 | 10-K | 11 Aug 2025 | 2025 | FY | |
| 2023 | -1.8 | -1.58 | -718% | 01 May 2023 | 30 Apr 2024 | 10-K | 11 Aug 2025 | 2025 | FY |
| 2022 | -0.22 | +0.05 | +19% | 01 May 2022 | 30 Apr 2023 | 10-K | 13 Aug 2024 | 2024 | FY |
| 2021 | -0.27 | +2.18 | +89% | 01 May 2021 | 30 Apr 2022 | 10-K | 31 Jul 2023 | 2023 | FY |
| 2020 | -2.45 | 01 May 2020 | 30 Apr 2021 | 10-K | 28 Jul 2022 | 2022 | FY | ||
| 2013 | -0.05 | -0.05 | 01 May 2013 | 30 Apr 2014 | 10-K | 04 Aug 2014 | 2014 | FY | |
| 2012 | 0 | +0.01 | 01 May 2012 | 30 Apr 2013 | 10-K | 04 Aug 2014 | 2014 | FY | |
| 2011 | -0.01 | -0.01 | 01 May 2011 | 30 Apr 2012 | 10-K | 29 Jul 2013 | 2013 | FY | |
| 2010 | 0 | 01 May 2010 | 30 Apr 2011 | 10-K | 14 Aug 2012 | 2012 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.